Literature DB >> 10697800

Cysteine protease inhibitory activity and levels of salivary cystatins in whole saliva of periodontally diseased patients.

A C Baron1, S A Gansky, M I Ryder, J D Featherstone.   

Abstract

The 3 human salivary cystatins S, SA and SN are multifunctional proteins that possess a cysteine protease inhibitory property, but their ability to act as such is very different (SN > SA >> S). One form, S, also appears to possess antibacterial properties towards the bacterium Porphyromonas gingivalis, often associated with periodontal diseases. In this study we measured the total cystatin inhibitory activity and the levels of each salivary cystatin in the whole saliva of 8 periodontally diseased patients and 2 groups of control subjects (n = 6 and n = 10). The total cystatin inhibitory activity and the total salivary cystatin concentration in the periodontally diseased patients were found to be lower than the controls (p < or = 0.005). The concentration of S was depleted to levels that would not allow it to be an effective antibacterial agent, and the concentration of SA, although depleted in some cases, was still present at sufficient levels to allow it to act as an effective physiological inhibitor of cathepsin L. The concentration of cystatin SN was also depleted in the periodontally diseased patients, but was still present in sufficient quantities to act as an effective physiological cysteine protease inhibitor of cathepsins H and L. In comparison, the concentration of all 3 salivary cystatins in the control subjects were sufficient to enable these proteins to be both effective physiological cysteine protease inhibitors and antibacterial agents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10697800     DOI: 10.1111/j.1600-0765.1999.tb02279.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  7 in total

Review 1.  Antimicrobial peptides in periodontal innate defense.

Authors:  Sven-Ulrik Gorr
Journal:  Front Oral Biol       Date:  2011-11-11

2.  Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteases.

Authors:  Asaf Sol; Yaniv Skvirsky; Rizan Nashef; Katya Zelentsova; Tal Burstyn-Cohen; Edna Blotnick; Andras Muhlrad; Gilad Bachrach
Journal:  J Biol Chem       Date:  2014-06-19       Impact factor: 5.157

3.  Targeted Proteomics Guided by Label-free Quantitative Proteome Analysis in Saliva Reveal Transition Signatures from Health to Periodontal Disease.

Authors:  Nagihan Bostanci; Nathalie Selevsek; Witold Wolski; Jonas Grossmann; Kai Bao; Asa Wahlander; Christian Trachsel; Ralph Schlapbach; Veli Özgen Öztürk; Beral Afacan; Gulnur Emingil; Georgios N Belibasakis
Journal:  Mol Cell Proteomics       Date:  2018-04-02       Impact factor: 5.911

4.  Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies.

Authors:  Patricia Yen Bee Ng; Maureen Donley; Ernest Hausmann; Alan D Hutson; Edward F Rossomando; Frank A Scannapieco
Journal:  FEMS Immunol Med Microbiol       Date:  2007-03

5.  Putative salivary protein biomarkers for the diagnosis of oral lichen planus: a case-control study.

Authors:  Sineepat Talungchit; Waranun Buajeeb; Chotima Lerdtripop; Rudee Surarit; Kongthawat Chairatvit; Sittiruk Roytrakul; Hiroaki Kobayashi; Yuichi Izumi; Siribang-On Piboonniyom Khovidhunkit
Journal:  BMC Oral Health       Date:  2018-03-13       Impact factor: 2.757

Review 6.  The Relationship Between Salivary Redox, Diet, and Food Flavor Perception.

Authors:  Mathieu Schwartz; Fabrice Neiers; Gilles Feron; Francis Canon
Journal:  Front Nutr       Date:  2021-01-28

7.  Top-Down Proteomics of Human Saliva Discloses Significant Variations of the Protein Profile in Patients with Mastocytosis.

Authors:  Simone Serrao; Davide Firinu; Alessandra Olianas; Margherita Deidda; Cristina Contini; Federica Iavarone; M Teresa Sanna; Mozhgan Boroumand; Francisco Amado; Massimo Castagnola; Irene Messana; Stefano Del Giacco; Barbara Manconi; Tiziana Cabras
Journal:  J Proteome Res       Date:  2020-07-06       Impact factor: 4.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.